Jason Quill, PhD, is a medtech founder with deep experience advancing structural heart and interventional technologies from concept through first‑in‑human evaluation. He holds more than 100 issued patents across annuloplasty, transcatheter delivery, and procedural tools, and previously contributed to next‑generation valve delivery systems and multimodal imaging frameworks at Medtronic’s Structural Heart division. Jason now leads Throughline, a structured development platform supporting early‑stage innovators in electrophysiology and structural heart, as well as Coaptis, a startup in the structural heart space.